Home The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
Article
Licensed
Unlicensed Requires Authentication

The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation

  • Christine Lauro EMAIL logo , Margaret E. Macy , Philip Zeitler , Jennifer Backus , Pamela Mettler , Nicholas Foreman and Arthur K. Liu
Published/Copyright: September 20, 2013

Abstract

Purpose: The aim of this work is to determine if a relationship exists between thyroid dose and incidence of primary hypothyroidism (PH) in children undergoing craniospinal irradiation (CSI).

Methods: A total of 22 patients received CSI with evaluable thyroid dose information. All patients received concurrent chemotherapy and 21 patients (95%) received adjuvant chemotherapy. Median follow-up was 42.9 months.

Results: The incidence of PH in our cohort was 59% at a median time after radiotherapy of 3.5 years (range: 8 months to 7.5 years). Mean thyroid dose appeared to best predict for PH, with a median of 2080 cGy for patients with PH versus 1736 cGy for children without PH (p=0.057). There was no association between the rate of PH and sex, age, CSI dose, minimum thyroid dose and maximum thyroid dose.

Conclusions: A relationship may exist between the mean thyroid dose and incidence of PH in patients undergoing CSI. Thus, new strategies to protect the thyroid gland may be warranted.


Corresponding author: Christine Lauro, MD, University of Colorado-Radiation Oncology, Mail Stop F706 1665 Aurora Court, Suite 1032, Aurora, CO 80045, USA, Phone: +1-720-848-0106, Fax: +1-720-848-0222, E-mail:

References

1. Duffner PK, Cohen ME, Anderson SW, Voorhess ML, MacGillivray MH, et al. Long-term effects of treatment on endocrine function in children with brain tumors. Ann Neurol 1983;14:528–32.Search in Google Scholar

2. Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumors. Arch Dis Child 1989;64:593–5.Search in Google Scholar

3. Ogilvy-Stuart AL, Shalet SM, Gottamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991;119:733–7.Search in Google Scholar

4. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87–94.Search in Google Scholar

5. Chin D, Sklar C, Donahue B, Uli N, Geneiser N, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997;80:798–804.Search in Google Scholar

6. Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002;53:543–7.Search in Google Scholar

7. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, et al. Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 1984;53:878–83.Search in Google Scholar

8. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165–70.Search in Google Scholar

9. Kuten A, Lubochitski R, Fishman G, Dale J, Stein ME. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at <40 Gy. J Surg Oncol 1996;61:281–3.Search in Google Scholar

10. Sklar C, Whitton J, Mertens A, Stovall M, Green D, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: date from the Child Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227–32.Search in Google Scholar

11. Boomsma MJ, Bijl H, Langendijk JA. Radiation-induced hypthyroidism in head and neck cancer patients: a systemic review. Radiother Oncol 2011;99:1–5.Search in Google Scholar

12. Marks LB, Yorke E, Jackson A, Ten Haken RK, Constine LS, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76:s10–19.Search in Google Scholar

13. Bakhshandeh M, Hashemi B, Mahdavi SR, Nikoofar A, Vasheghani M, et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys 2010;85:514–21.Search in Google Scholar

14. Emami B, Lyman J, Brown A, Coia L, Goitein M, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109–122Search in Google Scholar

15. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006;24:4202–8.Search in Google Scholar

16. Turkkahraman D, Alper OM, Aydin F, Yildiz A, Pehlivanoglu S, et al. Final diagnosis in children with sublinical hypothyroidism and mutation analysis of the thyroid peroxidase gene (TPO). J Pediatr Endocrinol Metab 2011;22:767–873.Search in Google Scholar

17. Bonato C, Severino RF, Elnecave RH. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treted with radiotherapy. J Clin Endocrinol Metab 2008;21: 943–9.Search in Google Scholar

18. Tell R, Lundell G, Nilsson B, Sjödin H, Lewin F, et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:395–400.Search in Google Scholar

19. Bhatia S, Ramsay NK, Bantle JP, Mertens A, Robison LL. Thyroid abnormalities after therapy for Hodgkin’s disease in childhood. Oncologist 1996;1:62–7.Search in Google Scholar

20. Fogliata A, Bergström S, Cafaro I, Clivio A, Cozzi L, et al. Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience. Radiother Oncol 2011;99:79–85.Search in Google Scholar

21. Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362–72.Search in Google Scholar

22. Massimino M, Gandola L, Pignoli E, Seregni E, Marchianò A, et al. TSH suppression as a possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma. Pediatr Blood Cancer 2011;57:166–8.Search in Google Scholar

Received: 2013-2-25
Accepted: 2013-8-20
Published Online: 2013-09-20
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Downloaded on 20.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0063/html
Scroll to top button